Tesaro Inc said its experimental ovarian cancer drug niraparib met the main goal of prolonging survival in patients, without the disease worsening, in a late-stage trial, sending its shares to a record high. The Waltham, Massachusetts-based company’s shares more than doubled to $77. Read more. Source: Reuters
Impax Buys Generic Drugs from Teva, Allergan for $586M
Impax Laboratories Inc said it would buy a portfolio of generic drugs from Teva Pharmaceutical Industries Ltd and Allergan Plc for about $586 million. The deal is part of the divestiture process mandated by the U.S. Federal Trade Commission in relation to Teva’s acquisition of Allergan’s generics business for $40.5 billion. Read more. Source: Reuters